JPRN-UMIN000013154已完成未知
A clinical study of relevance to KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer - A relevance to KRAS mutations and acquired resistance to anti-EGFR therapy
Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences0 个研究点目标入组 20 人开始时间: 2014年4月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •He or she had used anti-EGFR antibody previously, or prohibit on using anti-EGFR antibody
研究者
相似试验
招募中
Unknown
Evaluation the clinical utility of KRAS mutation assay using tumor samples (tissue, cytology) and blood samples in patients with pancreatic cancer.pancreatic cancerJPRN-UMIN000052237St.Marianna University School of Medicine100
招募中
不适用
Clinical relevance of KRAS and GNAS Mutationen in cell-free DNA and circulating epithelial cells regarding the development of pancreatic cancer in IPMN patientsD13.6PancreasDRKS00023356niversitätsklinikum Hamburg-Eppendorf100
尚未招募
不适用
Prevalence of two mutations (KRAS and BRAF) in patients diagnosed with Colorectal Cancer.CTRI/2013/09/004023Dr Prachi S Patil200
已完成
不适用
Prevalence of the Mutational Status of V-Ki-ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) in Metastatic Colorectal Cancer (mCRC) in Argentine PatientsColorectal NeoplasmsNCT01082757Merck KGaA, Darmstadt, Germany1,524
已完成
不适用
KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009Colorectal CarcinomaNCT01151007University Hospital Center of Martinique250